StockData
Chemours Co logo

Chemours Co (CC) stock

CCNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$12.09−0.09 (-0.74%)

Close on Nov 18, 2026Market cap $1.82BP/E –Yield 4.24%

Chemours net income

Net income is the profit left for shareholders after every expense, interest and tax.

Chemours's net income for the twelve months ending Jun 30, 2026 was -$304.00M. For fiscal 2025 it was -$386.00M, down 659.4% from the year before. The highest annual figure on record is $995.00M in fiscal 2018.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$386.00M-659.4%
FY2024Dec 31, 2024$69.00M–
FY2023Dec 31, 2023-$253.00M-143.8%
FY2022Dec 31, 2022$578.00M-4.9%
FY2021Dec 31, 2021$608.00M+177.6%
FY2020Dec 31, 2020$219.00M–
FY2019Dec 31, 2019-$52.00M-105.2%
FY2018Dec 31, 2018$995.00M+33.4%
FY2017Dec 31, 2017$746.00M+10557.1%
FY2016Dec 31, 2016$7.00M–
FY2015Dec 31, 2015-$90.00M-122.5%
FY2014Dec 31, 2014$400.00M-5.4%
FY2013Dec 31, 2013$423.00M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$274.00M–
Q1 FY2026Mar 31, 2026-$29.00M–
Q4 FY2025Dec 31, 2025-$47.00M–
Q3 FY2025Sep 30, 2025$46.00M–
Q2 FY2025Jun 30, 2025-$380.00M-733.3%
Q1 FY2025Mar 31, 2025-$5.00M-109.3%
Q4 FY2024Dec 31, 2024-$11.00M–
Q3 FY2024Sep 30, 2024-$32.00M-366.7%
Q2 FY2024Jun 30, 2024$60.00M–
Q1 FY2024Mar 31, 2024$54.00M-62.8%
Q4 FY2023Dec 31, 2023-$18.00M–
Q3 FY2023Sep 30, 2023$12.00M-95.0%
Q2 FY2023Jun 30, 2023-$376.00M-287.1%
Q1 FY2023Mar 31, 2023$145.00M-38.0%
Q4 FY2022Dec 31, 2022-$97.00M-141.6%
Q3 FY2022Sep 30, 2022$240.00M+12.1%
Q2 FY2022Jun 30, 2022$201.00M+204.5%
Q1 FY2022Mar 31, 2022$234.00M+143.8%
Q4 FY2021Dec 31, 2021$233.00M+1126.3%
Q3 FY2021Sep 30, 2021$214.00M+181.6%
Q2 FY2021Jun 30, 2021$66.00M+175.0%
Q1 FY2021Mar 31, 2021$96.00M-4.0%
Q4 FY2020Dec 31, 2020$19.00M–
Q3 FY2020Sep 30, 2020$76.00M0.0%
Q2 FY2020Jun 30, 2020$24.00M-75.0%
Q1 FY2020Mar 31, 2020$100.00M+6.4%
Q4 FY2019Dec 31, 2019-$317.00M-323.2%
Q3 FY2019Sep 30, 2019$76.00M-72.4%
Q2 FY2019Jun 30, 2019$96.00M-65.8%
Q1 FY2019Mar 31, 2019$94.00M-68.4%
Q4 FY2018Dec 31, 2018$142.00M-37.7%
Q3 FY2018Sep 30, 2018$275.00M+32.9%
Q2 FY2018Jun 30, 2018$281.00M+74.5%
Q1 FY2018Mar 31, 2018$297.00M+98.0%
Q4 FY2017Dec 31, 2017$228.00M–
Q3 FY2017Sep 30, 2017$207.00M+1.5%
Q2 FY2017Jun 30, 2017$161.00M–
Q1 FY2017Mar 31, 2017$150.00M–
Q4 FY2016Dec 31, 2016-$230.00M–
Q3 FY2016Sep 30, 2016$204.00M–

More Chemours figures

See a number that looks wrong?